GLYC - GlycoMimetics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue--18.520,070.75
Cost of Revenue----
Gross Profit--18.520,070.75
Operating Expenses
Research Development40,091.77324,100.09223,281.8225,050.179
Selling General and Administrative11,413.059,832.1888,650.1657,805.396
Non Recurring----
Others----
Total Operating Expenses51,504.82333,932.2831,931.98532,855.575
Operating Income or Loss-51,504.823-33,932.28-31,913.485-12,784.825
Income from Continuing Operations
Total Other Income/Expenses Net3,231.19651.212103.64715.327
Earnings Before Interest and Taxes-51,504.823-33,932.28-31,913.485-12,784.825
Interest Expense----
Income Before Tax-48,273.633-33,281.068-31,809.838-12,769.498
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-48,273.633-33,281.068-31,809.838-12,769.498
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-48,273.633-33,281.068-31,809.838-12,769.498
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-48,273.633-33,281.068-31,809.838-12,769.498